Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: a systematic review and meta-analysis
Abstract Background Epicardial adipose tissue (EAT) plays an important role in cardiometabolic risk. EAT is a modifiable risk factor and could be a potential therapeutic target for drugs that already show cardiovascular benefits. The aim of this study is to evaluate the effect of cardiometabolic dru...
Main Authors: | Veronika A. Myasoedova, Valentina Parisi, Donato Moschetta, Vincenza Valerio, Maddalena Conte, Ilaria Massaiu, Michele Bozzi, Fabrizio Celeste, Dario Leosco, Guido Iaccarino, Stefano Genovese, Paolo Poggio |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-01-01
|
Series: | Cardiovascular Diabetology |
Online Access: | https://doi.org/10.1186/s12933-023-01738-2 |
Similar Items
-
Extraction-Free Absolute Quantification of Circulating miRNAs by Chip-Based Digital PCR
by: Yuri D’Alessandra, et al.
Published: (2022-06-01) -
Epicardial Adipose Tissue and Cardiac Arrhythmias: Focus on Atrial Fibrillation
by: Maddalena Conte, et al.
Published: (2022-06-01) -
Epicardial Adipose Tissue and Postoperative Atrial Fibrillation
by: Laura Petraglia, et al.
Published: (2022-02-01) -
Anti-Inflammation and Anti-Oxidation: The Key to Unlocking the Cardiovascular Potential of SGLT2 Inhibitors and GLP1 Receptor Agonists
by: Veronika A. Myasoedova, et al.
Published: (2023-12-01) -
Purinergic Receptor P2Y2 Stimulation Averts Aortic Valve Interstitial Cell Calcification and Myofibroblastic Activation
by: Donato Moschetta, et al.
Published: (2022-02-01)